Intravitreal Amphotericin B Treatment of Candida Endophthalmitis
- 1 January 1977
- journal article
- case report
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 95 (1), 89-93
- https://doi.org/10.1001/archopht.1977.04450010089008
Abstract
• A 43-year-old heroin addict with Candida albicans endophthalmitis was treated with a single 5-μg intravitreal injection of amphotericin B. The diagnosis was confirmed by smears and cultures of a vitreous aspiration. The patient's accidental death seven weeks after treatment enabled us to obtain histopathologic evidence that the infection had been cured and that the amphotericin B had had no toxic effect on the retina. Intravitreal amphotericin B should be considered an important mode of treatment of Candida endophthalmitis. (Arch Ophthalmol 95:89-93, 1977)This publication has 10 references indexed in Scilit:
- Spontaneous Resolution of Endogenous Candida Endophthalmitis Complicating Intravenous HyperalimentationAmerican Journal of Ophthalmology, 1975
- Intravitreal Amphotericin B ToxicityAmerican Journal of Ophthalmology, 1974
- Endogenous Fungal Endophthalmitis in a Drug AddictAmerican Journal of Ophthalmology, 1974
- Candida Endophthalmitis Associated With Intravenous HyperalimentationArchives of Surgery, 1974
- Candida Endophthalmitis Complicating CandidemiaAnnals of Internal Medicine, 1973
- Intravitreal Amphotericin B Treatment of Experimental Fungal EndophthalmitisAmerican Journal of Ophthalmology, 1973
- Toxicity of Intravitreal Injection of Amphotericin BAmerican Journal of Ophthalmology, 1973
- ENDOGENOUS FUNGUS ENDOPHTHALMITISActa Ophthalmologica, 1971
- The Major Medical Complications of Heroin AddictionAnnals of Internal Medicine, 1967
- Ocular Penetration of Amphotericin BArchives of Ophthalmology (1950), 1965